Apo-Fenofibrate · DIN 02225980 · 100 mg · capsule
General benefitDormant since January 5, 2022 · checked November 19, 2026 · What does dormant mean?
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Apo-Fenofibrate · DIN 02225980
Manufacturer: Apotex Inc.; listing date 1996-12-19
Health Canada: Dormant since 2022-01-05 · brand FENOFIBRATE · ATC C10AB05 FENOFIBRATE · form Capsule · route Oral · ingredients FENOFIBRATE 100 MG · company Aa pharma inc · schedule Prescription
Apo-Fenofibrate: Formulary list price $0.61 per unit (the source does not state the unit; exact figure $0.6105). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02225980)
Source record
DIN 02225980: Apo-Fenofibrate
Raw flags: chronicUseMed=Y, sec3=Y
Item: 240600018; group id 303; item number 0657; lccId None; manufacturer id APX
Source form: Cap; strength: 100mg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.6105; ministry $0.6105
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02225980
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=43440
Interchangeable products
Lipidil · DIN 00885827 · not recorded
Shortage status: not checked (no credentials)
Health Canada lists this DIN as Dormant since January 5, 2022 — choose a marketed DIN from the same-category list.